A practical approach to diagnosing and managing long QT syndrome from pregnancy through postpartum - ScienceDirect by ⁦Andrew H. Nguyen, DO⁩ ⁦InovaCVfellows⁩ ⁦Inova Schar Heart and Vascular⁩ and supported by Inova Cardio OB and MFM sciencedirect.com/science/articl…

Expert Review in Am J Obstet Gynecol MFM by members of Inova Schar Heart and Vascular and Inova OB-GYN team presenting approach to deal with unique challenges of managing LQTS from prenancy to post partum Andrew H. Nguyen, DO Garima Sharma M.D Christopher O'Connor sciencedirect.com/science/articl…

Inova received Press Ganey Award for highest quality, safety, patient experience “Proud that our focus on excellence contributed to this achievement” Inova Schar Heart and Vascular President Christopher O'Connor noted “An honor to be part of healthcare system receiving this prestigious national recognition”

2025 US guidelines for the management of ACS (STEMI and NSTE-ACS) just released. Insertion of a microaxial flow pump (Impella) to prevent death in in cardiogenic shock has received a class IIa LOE B-R recommendation. IABP and VA-ECMO are class III for rourine use.

First American College of Cardiology Concise Clinical Guidance (CCG) streamlines processes for implementing best practices in patient care. This CCG focuses on evaluating & managing #cardiogenicshock, answering 🔑 clinical questions & providing actionable guidance. jacc.org/doi/10.1016/j.… #JACC

Excited to announce this important contribution to Evaluating and Managing Cardiogenic Shock, led by Inova Schar Heart and Vascular Director, Cardiogenic Shock Program, Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA. Critical guidance for clinical decision-making. Navin Kapur Christopher O'Connor Behnam N. Tehrani, MD Alex Truesdell

Honored to chair & lead 1st American College of Cardiology Concise Clinical Guidance on #CardiogenicShock designed to help clinicians across ALL hospitals to SUSPECT & manage CS Many🙏#DrDavidMorrow Navin Kapur Rachna Kataria, MD Robert Roswell for collaboration! JACC Journals Inova Schar Heart and Vascular Inova

Inova Cardiogenic 💥🫀⚡️Shock and Heart Failure Regional Symposium and Think Tank: Coming Soon 👍: 🔗 advancedhfsymposium.com/program/…

The Inova Schar Heart and Vascular team shines at #ACC25 Saturday highlights Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA · Co-chair Elvis’s Heartbreak Hotel: Critical Issues in Managing Cardiogenic Shock · Teams – Cross the bridge together: Transplant, MCS or Recovery? Posters below American College of Cardiology Christopher O'Connor

Each year my excitement for ACC grows! Especially this year in Chicago, where I completed my medical training. Grateful to be presenting a moderated poster during the Complex Clinical Cases session! 🫀 #ACC25 InovaCVfellows Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA Ilan Vavilin American College of Cardiology

Massive hemoptysis due to eroded pacemaker leads into the lung 🫁🩸 Presented at #ACC25 Moderated Digital Poster Sessions. 🫀📣 Thanks to my mentors and colleagues Ilan Vavilin @mutazalkalbani InovaCVfellows Inova Schar Heart and Vascular American College of Cardiology Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA

First day at #ACC25, here are the results of 10 trials presented today. I counted 3 NEJM, 1 Lancet, and 1 JAMA. WARRIOR: Intensive medical therapy did not reduce major CV events at five years in women with suspected INOCA. STRIDE: Semaglutide improved walking distance, symptoms,

Medical residents, aspiring cardiologists, & soon to be fellow Inova take on American College of Cardiology #ACC25 🫀💥Inova Schar Heart and Vascular InovaCVfellows

Look out #ACC25! So proud of you Christopher O'Connor Garima Sharma M.D Jamie Kennedy Vanessa Blumer, MD, FACC

ACC 2025 LATE BREAKING CLINICAL TRIALS - One LINER SUMMARY 📸 AT A GLANCE ⭐️ What a phenomenal scientific meeting! Congratulations to all the presenters &research leaders for yet another fantastic year of innovation & research. 🫀❤️ 😊 #ACC2025 American College of Cardiology UW-Madison Division of Cardiovascular Medicine CardioNerds

Excited to share our expert analysis of the FAVOR-III Europe trial published in American College of Cardiology. Thank you Hooman Bakhshi and Ilan Vavilin for the opportunity! Inova Schar Heart and Vascular InovaCVfellows Inova acc.org/Latest-in-Card…

FAVOR III Europe was a multicenter, randomized, open-label, noninferiority trial to compare clinical outcomes of QFR-guided & FFR-guided #revascularization in patients with intermediate coronary stenosis at 12 months. Learn more: bit.ly/43jMoXe #CardioX

Please read our latest expert analysis for FAVOR III Europe clinical trial lead by superstar Inova Schar Heart and Vascular resident Andrew H. Nguyen, DO . Ilan Vavilin InovaCVfellows Christopher O'Connor Matthew Sherwood, MD, MHS Behnam N. Tehrani, MD Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA Garima Sharma M.D American College of Cardiology Maryland Chapter, American College of Cardiology Virginia Chapter, American College of Cardiology

Cardiovascular Disease Fellowship Program Inova Schar Heart and Vascular Honored to train the next leaders in the field · World Class Faculty · Dedicated Mentoring · Complex Patient Care · Outstanding Research Opportunities · Commitment to Innovation and Excellence vimeo.com/1098619654

Happy hour, happy hearts! At Inova Schar Heart and Vascular , InovaCVfellows train together, grow together, and celebrate together 🫀💙 Iyad Isseh إياد نبيل العسّة Christopher O'Connor Garima Sharma M.D Jamie Kennedy